Rchr
J-GLOBAL ID:200901088216865858   Update date: Mar. 29, 2020

Oikawa Taku

オイカワ タク | Oikawa Taku
Affiliation and department:
Job title: Research Associate
Papers (32):
  • ラット実験アミオダロン肺障害モデルにおける肺サーファクタント恒常性の変化. 2018. 22. 1. 99-101
  • Nojiri Masafumi, Mizuno Shiro, Nishiki Kazuaki, Kato Ryo, Nakagawa Ken, Oikawa Taku, Iguchi Masaharu, Osanai Kazuhiro, Ishizaki Takeshi, Toga Hirohisa. ADRB2 gene polymorphism and emphysema heterogeneity can modulate bronchodilator response in patients with emphysema. Pulmonary pharmacology & Therapeutics. 2018. 48. 80-87
  • Shiro Mizuno, Takeshi Ishizaki, Maiko Kadowaki, Masaya Akai, Kohei Shiozaki, Masaharu Iguchi, Taku Oikawa, Ken Nakagawa, Kazuhiro Osanai, Hirohisa Toga, Jose Gomez-Arroyo, Donatas Kraskauskas, Carlyne D. Cool, Herman J. Bogaard, Norbert F. Voelkel. p53 Signaling Pathway Polymorphisms Associated With Emphysematous Changes in Patients With COPD. CHEST. 2017. 152. 1. 58-69
  • Masafumi.Nojiri, Shiro.Mizuno, Kazuaki.Nishiki, Ryo.Kato, Ken.Nakagawa, Taku.Oikawa, Masaharu.Iguchi, Kazuhiro.Osanai, Takeshi.Ishizaki, Hirohisa.Toga. ADRB2 gene polymorphism and emphysema heterogeneity can modulate bronchodilator response in patients with emphysema. Pulmonary Pharmacology & Therapeutics. 2017. 48(2018). 80-87
  • Y.Takahara, K.Nishiki, K.Nakase, R.Kato, S.Shinomiya, M.Saito, K.Kojima, Y.Fujimoto, K.Nakagawa, T.Oikawa, S.Mizuno, K.Osanai, H.Toga. A Case of Diffuse Pleural Invasion of Pseudomesotheliomatous Carcinoma with EGFR Mutation Diagnosed by Thoracoscopic Biopsy. The Journal of the Japan Society for Respiratory Endoscopy. 2016. 38. 3. 183-189
more...
Lectures and oral presentations  (220):
  • 家族内発症を認めた慢性過敏性肺炎の一例(呼)
    (2018)
  • 睡眠時無呼吸症候群患者における高炭酸ガス換気応答の検討(呼)
    (2018)
  • Propionibacterium acnesによる膿胸の1例(呼)
    (2018)
  • ペースメーカー背側に発症した小細胞肺癌の1例
    (2018)
  • 胸部異常陰影を呈した抗SRP抗体陽性多発筋炎の1例
    (2018)
more...
Professional career (1):
  • Ph.D in Medicine
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page